Skip to main content
. 2018 Apr 28;218(6):886–891. doi: 10.1093/infdis/jiy250

Figure 2.

Figure 2.

A, IgA-specific gp350 antibody dynamics in nasopharyngeal carcinoma (NPC) cases relative to time of diagnosis. B, Epstein-Barr virus (EBV) total gp350 antibody dynamics in NPC cases relative to time of diagnosis. Abbreviation: LIPS, luciferase immunoprecipitation.